HEALTHSTREAM INC Q1 FY2025 earnings call

Strengths include experienced management, diverse product offering meeting mandatory needs, strong sales pipelines, and successful bundling. Challenges: Macro-economic headwinds affecting elective content, temporary tech scaling issues with CredentialStream, and delayed medium-sized deals. Operational highlights: Landed a $14 million largest-ever deal, strong CredentialStream growth, successful Thrive25 Conference, and Board additions (welcome of Charles Beard, Jr. and departure of Dr. William Stead).

Revenues for the first quarter were $73.5 million, up 1% year-over-year. Operating income was $4.4 million, down 23.1%; net income was $4.3 million, down 17.1%; EPS was $0.14 per share, down from $0.17. Adjusted EBITDA was $16.2 million, down 5%. Core products: ShiftWizard (Scheduling) had 19% revenue growth, surpassing legacy ANSOS in Q2 2024. CredentialStream (Credentialing) saw 25% growth with migrations from legacy apps and new customers. Learning Application suite, including Continuing Medical Education modules and Insight Plus, showed growth. Remaining performance obligations were $613 million as of Q1 2025, with ~40% converted to revenue over 12 months and ~68% over 24 months.

Revised guidance: Consolidated revenues range $297.5M - $303.5M, net income $18.6M - $21M, adjusted EBITDA $68.5M - $72.5M. Factors: Delayed revenue from medium-sized deals and tech issues, but confident in growth via diverse products and mandatory needs.

Macro-economic headwinds impacting elective purchasing; temporary tech scaling issues with CredentialStream; legacy product challenges (losses from ANSOS, Morrissey, Healthline) with uncertainty around customer migration/retention.

Q: Quantify mandatory vs elective products in portfolio A: Most products tied to requirements (credentialing, resuscitation, OSHA, licensure). Elective like Health Equity and Belonging content saw drop-off.

Q: Nature of largest deal in Q1 A: New business, $14 million deal with large health system, bundling Competency suite displacing competitors.

Q: Legacy product timeline A: Legacy products supported but not sold new; outcomes include staying, migrating, or loss; migration is goal but conversion varies.

Q: Pricing pushback A: Bundling helps, with 3%-5% annual pricing escalators in contracts.

Q: Acquisition impact of economic uncertainty A: Active but disciplined, not chasing overpriced deals, seeing more deal flow but conservative.